Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechSci Research | PRODUCT CODE: 1073074

Cover Image

PUBLISHER: TechSci Research | PRODUCT CODE: 1073074

Global Eye Drop Market, By Type, By Drug Class, By Disease Indication, By Distribution Channel, By Region, Competition Forecast and Opportunities, 2027

PUBLISHED:
PAGES: 110 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4900
PDF and Excel (Multi-User License)
USD 5900
PDF and Excel (Custom Research License)
USD 8900

Add to Cart

We offer 8 hour analyst time for an additional research. Please contact us for the details.

Global eye drop market was valued at USD13530 million in 2021 and is anticipated to grow with a CAGR of 6.46% during the forecast period to achieve a market value of USD19758 million by 2027. The market is anticipated to grow on account of increasing instances of eye infection in the population. Higher prevalence of eye diseases like eye dryness, redness, itching in the eyes, conjunctivitis, soreness, glaucoma, etc. further drive the growth of the global eye drop market in the upcoming five years. Excessive screen time and penetration of smart phones, laptops, television, and electronics further supports the growth of the global eye drop market in the next five years. The governments around the world are actively investing in the healthcare industry and increasing the production of the pharmaceuticals and therapeutics products in the recent years. Growing imports & exports of the pharmaceutical & therapeutics products like eye drops further aid the growth of the global eye drop market in the future five years. Also, the consumers in the country have been spending over healthcare services to attain excellent patient care. Rising disposable income of the population also sustains the market growth. Technological advancement in product manufacturing, expanding logistics sector with easy distribution of the products further aids the growth of the global eye drop market in the forecast period.

The global eye drop market is segmented by type, drug class, disease indication, distribution channel, competitional landscape, and regional distribution. Based on type, the market is further differentiated into prescription and over the counter. Prescription type eye drops are anticipated to hold the largest revenue shares of the market and dominate the market segment in the upcoming five years on account of increasing instances of eye diseases. Increasing instances of diabetes and thus higher risks of catching eye diseases, vision impairment, also aids to the growth of the segment. Over the counter eye drops are expected to achieve the fastest growth owing to increasing tendency of the consumers to self-medicate their conditions of eye burning sensations and redness, etc. Increasing common eye itchiness and dryness due to prolonged screen times also aid to the growth of the sub-segment along with the growth of the global eye drops market in the future five years.

Johnson & Johnson Inc, Genentech, Inc. (Roche), Alcon Inc., Pfizer, Inc., Bausch Health Companies, Inc., Bayer Corporation, Allergan, Inc. (AbbVie), Abbott Laboratories, Inc., KC Pharmaceuticals, Inc., Akorn, Inc. are among the major market players in the global eye drop market.

Years considered for this report:

Historical Years: 2017- 2020

Base Year: 2021

Estimated Year: 2022E

Forecast Period: 2023F - 2027F

Objective of the Study:

  • To analyze the historical growth in the market size of global eye drop market from 2017 to 2021.
  • To estimate and forecast the market size of global eye drop market from 2022E to 2027F and growth rate until 2027F.
  • To classify and forecast global eye drop market based on type, drug class, disease indication, distribution channel, competitional landscape, and regional distribution.
  • To identify dominant region or segment in the global eye drop market.
  • To identify drivers and challenges for global eye drop market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global eye drop market.
  • To identify and analyze the profile of leading players operating in global eye drop market.
  • To identify key sustainable strategies adopted by market players in global eye drop market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global eye drop market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these products and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Eye drops manufacturers and suppliers
  • Distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to eye drops
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global eye drop market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Eye Drop Market, By Type:

Prescription

Over-The-Counter

  • Eye Drop Market, By Drug Class:

Anti-allergy

Anti-glaucoma

Anti-inflammatory

Anti-VEGF

Others

  • Eye Drop Market, By Disease Indication:

Eye Allergy

Glaucoma

Eye Infections

Dry Eye Diseases

Retinal Disorders

  • Eye Drop Market, By Distribution Channel:

Hospitals Pharmacy

Retail Pharmacy

Online Pharmacy

  • Eye Drop Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Russia Federation
  • United Kingdom
  • Germany
  • France
  • Spain
  • Italy

Asia-Pacific

  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Indonesia

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • Turkey
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global eye drop market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Product Code: 4539

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Eye Drop Market

5. Voice of Customer

  • 5.1. Brand Awareness
  • 5.2. Factors Contributing to demand for Eye Drops
  • 5.3. Demand, By Drug Class
  • 5.4. Demand, By Disease Indication
  • 5.5. Preference, By Distribution Channel

6. Global Eye Drop Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Prescription v/s Over-The-Counter)
    • 6.2.2. By Drug Class (Antiallergy, Anti-inflammatory, Antiglaucoma, Anti-VEGF, Others)
    • 6.2.3. By Disease Indication (Dry Eye Diseases, Glaucoma, Eye Allergy, Eye Infections, Retinal Disorders, Others)
    • 6.2.4. By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy)
    • 6.2.5. By Region
    • 6.2.6. By Company (2021)
  • 6.3. Product Market Map

7. North America Eye Drop Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Drug Class
    • 7.2.3. By Disease Indication
    • 7.2.4. By Distribution Channel
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Eye Drop Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Drug Class
        • 7.3.1.2.3. By Disease Indication
        • 7.3.1.2.4. By Distribution Channel
    • 7.3.2. Canada Eye Drop Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Drug Class
        • 7.3.2.2.3. By Disease Indication
        • 7.3.2.2.4. By Distribution Channel
    • 7.3.3. Mexico Eye Drop Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Drug Class
        • 7.3.3.2.3. By Disease Indication
        • 7.3.3.2.4. By Distribution Channel

8. Europe Eye Drop Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Drug Class
    • 8.2.3. By Disease Indication
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. Russia Federation Eye Drop Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Drug Class
        • 8.3.1.2.3. By Disease Indication
        • 8.3.1.2.4. By Distribution Channel
    • 8.3.2. United Kingdom Eye Drop Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Drug Class
        • 8.3.2.2.3. By Disease Indication
        • 8.3.2.2.4. By Distribution Channel
    • 8.3.3. Germany Eye Drop Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Drug Class
        • 8.3.3.2.3. By Disease Indication
        • 8.3.3.2.4. By Distribution Channel
    • 8.3.4. France Eye Drop Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Drug Class
        • 8.3.4.2.3. By Disease Indication
        • 8.3.4.2.4. By Distribution Channel
    • 8.3.5. Spain Eye Drop Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Drug Class
        • 8.3.5.2.3. By Disease Indication
        • 8.3.5.2.4. By Distribution Channel
    • 8.3.6. Italy Eye Drop Market Outlook
      • 8.3.6.1. Market Size & Forecast
        • 8.3.6.1.1. By Value
      • 8.3.6.2. Market Share & Forecast
        • 8.3.6.2.1. By Type
        • 8.3.6.2.2. By Drug Class
        • 8.3.6.2.3. By Disease Indication
        • 8.3.6.2.4. By Distribution Channel

9. Asia-Pacific Eye Drop Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Drug Class
    • 9.2.3. By Disease Indication
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Eye Drop Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Drug Class
        • 9.3.1.2.3. By Disease Indication
        • 9.3.1.2.4. By Distribution Channel
    • 9.3.2. India Eye Drop Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Drug Class
        • 9.3.2.2.3. By Disease Indication
        • 9.3.2.2.4. By Distribution Channel
    • 9.3.3. Japan Eye Drop Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Drug Class
        • 9.3.3.2.3. By Disease Indication
        • 9.3.3.2.4. By Distribution Channel
    • 9.3.4. Australia Eye Drop Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Drug Class
        • 9.3.4.2.3. By Disease Indication
        • 9.3.4.2.4. By Distribution Channel
    • 9.3.5. South Korea Eye Drop Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Drug Class
        • 9.3.5.2.3. By Disease Indication
        • 9.3.5.2.4. By Distribution Channel
    • 9.3.6. Indonesia Eye Drop Market Outlook
      • 9.3.6.1. Market Size & Forecast
        • 9.3.6.1.1. By Value
      • 9.3.6.2. Market Share & Forecast
        • 9.3.6.2.1. By Type
        • 9.3.6.2.2. By Drug Class
        • 9.3.6.2.3. By Disease Indication
        • 9.3.6.2.4. By Distribution Channel

10. South America Eye Drop Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Drug Class
    • 10.2.3. By Disease Indication
    • 10.2.4. By Distribution Channel
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Eye Drop Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Drug Class
        • 10.3.1.2.3. By Disease Indication
        • 10.3.1.2.4. By Distribution Channel
    • 10.3.2. Argentina Eye Drop Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Drug Class
        • 10.3.2.2.3. By Disease Indication
        • 10.3.2.2.4. By Distribution Channel
    • 10.3.3. Colombia Eye Drop Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Drug Class
        • 10.3.3.2.3. By Disease Indication
        • 10.3.3.2.4. By Distribution Channel

11. Middle East and Africa Eye Drop Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type
    • 11.2.2. By Drug Class
    • 11.2.3. By Disease Indication
    • 11.2.4. By Distribution Channel
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. Turkey Eye Drop Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Drug Class
        • 11.3.1.2.3. By Disease Indication
        • 11.3.1.2.4. By Distribution Channel
    • 11.3.2. South Africa Eye Drop Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Drug Class
        • 11.3.2.2.3. By Disease Indication
        • 11.3.2.2.4. By Distribution Channel
    • 11.3.3. Saudi Arabia Eye Drop Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Drug Class
        • 11.3.3.2.3. By Disease Indication
        • 11.3.3.2.4. By Distribution Channel
    • 11.3.4. UAE Eye Drop Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Type
        • 11.3.4.2.2. By Drug Class
        • 11.3.4.2.3. By Disease Indication
        • 11.3.4.2.4. By Distribution Channel
    • 11.3.5. Kuwait Eye Drop Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Type
        • 11.3.5.2.2. By Drug Class
        • 11.3.5.2.3. By Disease Indication
        • 11.3.5.2.4. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Johnson & Johnson Inc.
  • 14.2. Genentech, Inc. (Roche)
  • 14.3. Alcon Inc.
  • 14.4. Pfizer, Inc.
  • 14.5. Bausch Health Companies, Inc.
  • 14.6. Bayer Corporation
  • 14.7. Allergan, Inc. (AbbVie)
  • 14.8. Abbott Laboratories Inc.
  • 14.9. KC Pharmaceuticals, Inc.
  • 14.10. Akorn, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer

Product Code: 4539

List of Figures

  • Figure 1: Global Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 2: Global Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 3: Global Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 4: Global Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 5: Global Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 6: Global Eye Drop Market Share, By Region, By Value, 2017-2027F
  • Figure 7: Global Eye Drop Market Share, By Company, By Value, 2021
  • Figure 8: Global Eye Drop Market Map, By Type, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 9: Global Eye Drop Market Map, By Drug Class, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 10: Global Eye Drop Market Map, By Disease Indication, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 11: Global Eye Drop Market Map, By Distribution Channel, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 12: Global Eye Drop Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 13: North America Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 14: North America Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 15: North America Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 16: North America Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 17: North America Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 18: North America Eye Drop Market Share, By Country, By Value, 2017-2027F
  • Figure 19: United States Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 20: United States Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 21: United States Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 22: United States Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 23: United States Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 24: Canada Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 25: Canada Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 26: Canada Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 27: Canada Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 28: Canada Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 29: Mexico Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 30: Mexico Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 31: Mexico Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 32: Mexico Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 33: Mexico Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 34: Europe Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 35: Europe Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 36: Europe Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 37: Europe Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 38: Europe Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 39: Europe Eye Drop Market Share, By Country, By Value, 2017-2027F
  • Figure 40: Russia Federation Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 41: Russia Federation Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 42: Russia Federation Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 43: Russia Federation Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 44: Russia Federation Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 45: United Kingdom Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 46: United Kingdom Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 47: United Kingdom Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 48: United Kingdom Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 49: United Kingdom Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 50: Germany Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 51: Germany Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 52: Germany Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 53: Germany Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 54: Germany Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 55: France Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 56: France Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 57: France Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 58: France Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 59: France Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 60: Spain Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 61: Spain Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 62: Spain Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 63: Spain Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 64: Spain Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 65: Italy Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 66: Italy Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 67: Italy Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 68: Italy Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 69: Italy Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 70: Asia-Pacific Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 71: Asia-Pacific Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 72: Asia-Pacific Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 73: Asia-Pacific Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 74: Asia-Pacific Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 75: Asia-Pacific Eye Drop Market Share, By Country, By Value, 2017-2027F
  • Figure 76: China Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 77: China Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 78: China Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 79: China Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 80: China Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 81: India Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 82: India Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 83: India Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 84: India Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 85: India Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 86: Japan Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 87: Japan Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 88: Japan Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 89: Japan Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 90: Japan Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 91: Australia Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 92: Australia Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 93: Australia Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 94: Australia Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 95: Australia Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 96: South Korea Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 97: South Korea Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 98: South Korea Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 99: South Korea Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 100: South Korea Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 101: Indonesia Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 102: Indonesia Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 103: Indonesia Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 104: Indonesia Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 105: Indonesia Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 106: South America Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 107: South America Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 108: South America Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 109: South America Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 110: South America Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 111: South America Eye Drop Market Share, By Country, By Value, 2017-2027F
  • Figure 112: Brazil Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 113: Brazil Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 114: Brazil Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 115: Brazil Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 116: Brazil Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 117: Argentina Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 118: Argentina Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 119: Argentina Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 120: Argentina Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 121: Argentina Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 122: Colombia Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 123: Colombia Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 124: Colombia Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 125: Colombia Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 126: Colombia Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 127: Middle East & Africa Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 128: Middle East & Africa Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 129: Middle East & Africa Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 130: Middle East & Africa Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 131: Middle East & Africa Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 132: Middle East & Africa Eye Drop Market Share, By Country, By Value, 2017-2027F
  • Figure 133: Turkey Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 134: Turkey Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 135: Turkey Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 136: Turkey Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 137: Turkey Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 138: South Africa Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 139: South Africa Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 140: South Africa Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 141: South Africa Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 142: South Africa Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 143: Saudi Arabia Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 144: Saudi Arabia Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 145: Saudi Arabia Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 146: Saudi Arabia Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 147: Saudi Arabia Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 148: UAE Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 149: UAE Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 150: UAE Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 151: UAE Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 152: UAE Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 153: Kuwait Eye Drop Market Size, By Value (USD Million), 2017-2027F
  • Figure 154: Kuwait Eye Drop Market Share, By Type, By Value, 2017-2027F
  • Figure 155: Kuwait Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
  • Figure 156: Kuwait Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
  • Figure 157: Kuwait Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!